Comparison of Melphalan-Prednisone (MP) to MP Plus Thalidomide in the Treatment of Newly Diagnosed Very Elderly Patients (> 75 Years) With Multiple Myeloma - No Study Results Posted

Comparison of Melphalan-Prednisone (MP) to MP Plus Thalidomide in the Treatment of Newly Diagnosed Very Elderly Patients (> 75 Years) With Multiple Myeloma (IFM 01/01)

This study has been terminated.

( survival advantage demonstrated )

Study NCT00644306 Information provided by Central Hospital, Nancy, France

First Received: March 20, 2008 No Changes Posted

No Study Results Posted for this Study

About Study Results Reporting

Study Status:	This study has been terminated.
Study Completion Date:	May 2007
Estimated Primary Completion Date:	No date given